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Abstract
Background: The impact of multiple socio-economic deprivation on patient outcomes in primary renal diseases is un-
known. We aimed to assess whether risk of death or requiring renal replacement therapy (RRT) in patients with primary
glomerulonephritis (GN) was higher in patients living in an area of multiple socio-economic deprivation.
Methods: Patients undergoing native renal biopsy between 2000 and 2014 were identified. Baseline demographics, postcode
at time of biopsy, follow-up blood pressure, proteinuria and time to death or RRT were recorded. The Scottish Index of
Multiple Deprivation (SIMD) is a multidimensional model used to measure deprivation based on postcode. Using SIMD,
patients were separated into tertiles of deprivation.
Results: A total of 797 patients were included, 64.2% were male with mean age of 54.1 (standard deviation 17.0) years.
Median follow-up was 6.3 (interquartile range 3.7–9.4) years during which 174 patients required RRT and 185 patients died.
Patients in the most deprived tertile of deprivation were significantly more likely to die than those in the least deprived ter-
tile [hazard ratio (HR) 2.2, P < 0.001], independent of age, baseline serum creatinine and blood pressure. They were not
more likely to require RRT (P ¼ 0.22). The increased mortality risk in the most deprived tertile was not uniform across
primary renal diseases, with the association being most marked in focal segmental glomerulosclerosis (HR 7.4) and IgA
nephropathy (HR 2.7) and absent in membranous nephropathy.
Conclusion: We have demonstrated a significant independent 2-fold increased risk of death in patients with primary GNwho
live in an area of multiple socio-economic deprivation at the time of diagnosis as compared with those living in less deprived
areas.
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Introduction
In the general population, living in an area of multiple de-
privation has been shown to be associated with a significantly
reduced life expectancy compared with living in relative afflu-
ence [1]. Furthermore, the incidence of chronic kidney disease
(CKD) is higher in areas of socio-economic deprivation [2–4] and
patients who live in deprived areas are more likely to develop
end-stage renal disease (ESRD) [5].
In a healthcare system that is free at the point of access, we
have previously demonstrated a significant association be-
tween multiple socio-economic deprivation and the incidence
of IgA nephropathy (IgAN), an association not seen in other pri-
mary glomerulopathies [6]. What is not clear, however, is
whether living in an area of socio-economic deprivation im-
pacts upon patient outcomes in primary renal diseases.
The influence of socio-economic deprivation on health out-
comes is complex, with deprivation used as a surrogate for
factors including access to healthcare, health beliefs and behav-
iours, biological factors such as genetics, and environmental fac-
tors including housing, water supply and diseases [7]. It might be
hypothesized that once a condition is diagnosed and patients are
treated, population level inequalities would no longer apply, par-
ticularly in a healthcare setting that is free at the point of use.
We aimed to assess whether risk of death or requiring renal
replacement therapy (RRT) was higher in patients with primary
glomerulonephritis (GN) living in an area of multiple deprivation.
Materials and methods
Study population
The Glasgow Renal and Transplant Unit provides renal services
to the West of Scotland, population 1.6 million. Ninewells
Hospital Dundee (NWD) is located in the East of Scotland and
covers a population of 400 000. In 2007 the population of
Scotland was 5 144 200 [8], and therefore the two hospitals cover
over a third of the Scottish population.
Data sources
In all, 2827 consecutive adult patients who underwent native
renal biopsy between 2000 and 2012 (2000–14 at NWD) in the
two centres were identified. Of these, 859 patients had a diagno-
sis of primary GN. Patients with minimal change nephropathy
(n ¼ 62) were excluded from both cohorts as this is not a pro-
gressive proteinuric disease, leaving a cohort of 797 patients.
Using the Electronic Renal Patient Record, renal function,
proteinuria, blood pressure and postcode at the time of biopsy
were recorded. The mean value for blood pressure, and median
values for serum creatinine and urine protein to creatinine ratio
during follow-up for individual patients were recorded. Clinic
blood pressure every 3 months for the first 2 years after the
diagnosis were recorded were available. Time to RRT for ESRD
or death was noted.
Measure of multiple deprivation
The Scottish Index of Multiple Deprivation (SIMD) is a relative
ranking of all the geographical areas of Scotland produced by
the Scottish Government [9, 10]. The SIMD uses a multidimen-
sional model to assess deprivation, using 38 indicators across 7
domains. Each domain is weighted according to its importance
in the overall concept of multiple deprivation and robustness of
the indicators comprising the domain. The domains are as
follows: employment, income, crime, housing, health including
standardized mortality ratio, alcohol and drug misuse, educa-
tion and geographical and convenience access.
Scotland is geographically separated into 6505 areas (data-
zones) based on postcode with an average of 750 people living
in each. This ranking provides a relative measure of depriv-
ation, whereby one postcode area can be ranked relative to an-
other, but cannot be used to determine ‘how much’ more
deprived one area is compared with another.
Using the 2009 SIMD rankings, patients were separated into
tertiles of deprivation: Tertile 1 (SIMD 2009) datazones 1–2168
(most deprived); Tertile 2 (SIMD 2009) datazones 2169–4336;
Tertile 3 (SIMD 2009) datazones 4337–6505 (least deprived). The
postcode of the patient undergoing biopsy was then used to de-
termine his or her deprivation tertile.
Statistical analysis
Biopsy rate per million population per year was calculated.
Survival analysis was conducted using Cox proportional haz-
ards model. Statistics were calculated using IBM SPSS Statistics
version 22.
Ethics
The Scottish Renal Biopsy Registry has multisite ethical ap-
proval for data collection and epidemiological analysis.
Results
Baseline demographics
A total of 797 patients were included in the study cohort. In all,
64.2% were male with mean age of 54.1 (standard deviation 17.0)
years. Over 98% of patients were Caucasian. In all, 295 patients
had a diagnosis of IgAN [12.6 biopsies per million population
(PMP)/year], 189 focal segmental glomerulosclerosis (FSGS) (8.1
biopsies PMP/year), 185 membranous glomerulonephropathy
(MGN) (7.9 biopsies PMP/year) and 128 had other causes of pri-
mary glomerulonephritis (membranoproliferative GN, undiffer-
entiated GN, fibrillary and post-infectious GN). Table 1
demonstrates the baseline demographics of these groups. At
baseline, patients with MGN were older (mean age 59.7 years
versus 54.1 years overall) and had a lower mean serum creatin-
ine at diagnosis than other primary renal diseases.
The three tertiles of multiple socio-economic deprivation
were very similar in terms of age and gender distribution (Table
2). During follow-up, patients in the least deprived tertile
achieved better blood pressure control in the first 2 years after
diagnosis.
Outcomes
Overall, 174 patients required RRT, 185 died and 296 required
RRT or died. Eight patients were on RRT at the time of biopsy
and were excluded from analyses of risk of requiring RRT.
Median follow-up was 6.3 (interquartile range 3.7–9.4) years.
More patients with IgAN or ‘Other’ primary renal diseases
required RRT (Table 1). Time to RRT or death was shorter in pa-
tients with ‘Other’ primary renal diseases.
Patients in the most deprived tertile (Tertile 1) were signifi-
cantly more likely to die than those in Tertiles 2 or 3 (P < 0.001).
They were also significantly more likely to reach the combined
endpoint of death or RRT (P ¼ 0.005) but not the single endpoint
of requiring RRT (P ¼ 0.22) (Table 3).
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Using a multivariate Cox proportional hazards model, living
in a deprivation Tertile 1 area was independently associated
with a greater than 2-fold increase in the risk of death, inde-
pendent of age, baseline serum creatinine and blood pressure
(P ¼ 0.001) (Table 4, Figure 1). Primary renal disease was not an
independent predictor of risk of death, nor was gender.
Similarly, living in deprivation Tertile 1 (most deprived) was in-
dependently associated with a 50% increase in the risk of death
or requiring RRT compared with those living in Tertiles 2 or 3,
less deprived areas (P¼ 0.011).
In a univariate Cox proportional hazards modelling, living in
an area categorized as deprivation Tertile 1 was significantly
associated with an increased risk of requiring RRT (P¼ 0.04) but
this effect was not independent of serum creatinine at baseline
or baseline systolic blood pressure (Table 5).
To establish whether this effect is the same regardless of pri-
mary renal disease, the sensitivity analyses were repeated
examining membranous nephropathy, IgAN and FSGS alone.
Table 6 details the incidence of the primary endpoints by pri-
mary renal disease. In patients with membranous nephropathy,
living in an area of multiple socio-economic deprivation is not
associated with an increased risk of death (P¼ 0.87) or require-
ment for RRT (P¼ 0.64). Living in an area of multiple socio-
Table 1. Baseline demographics and outcomes—all patients and by primary renal disease
All cases
(n ¼ 797)
MGN, n ¼ 185
(23.2%)
IgAN, n ¼ 295
(37.0%)
FSGS, n ¼ 189
(23.7%)
Other, n ¼ 128
(16.1%)
Male (n, %) 512 (64.2%) 111 (60.0%) 211 (71.5%) 109 (57.7%) 81 (63.3%)
Age (years) 54.1 (17.0) 59.7 (16.0) 50.3 (16.4) 53.8 (16.8) 55.6 (17.0)
Baseline serum creat (lmol/L/1.73m2) 128 (90–207) 100 (79–150) 144 (100–230) 126 (90–181) 164 (100–310)
Baseline uPCR (mg/mmol) 346 (154–702) 317 (128–624) 343 (169–691) 411 (178–748) 302 (170–797)
SBP baseline (mmHg) 144 (24) 142 (25) 144 (20) 143 (28) 145 (23)
DBP baseline (mmHg) 80 (13) 77 (12) 81 (12) 80 (12) 78 (15)
SBP follow-up (mmHg) 134 (31) 133 (26) 133 (32) 135 (33) 135 (35)
DBP follow-up (mmHg) 74 (17) 72 (14) 76 (18) 74 (18) 73 (18)
uPCR follow-up (mg/mmol) 122 (49–314) 117 (40–323) 130 (51–312) 109 (45–348) 125 (60–373)
Follow-up (years) 6.3 (3.8–9.4) 6.2 (4.0–9.4) 6.2 (3.6–8.9) 7.1 (4.8–10.5) 5.3 (1.8–9.8)
RRT (n, %) 174 (21.8%) 27 (14.6%) 80 (27.1%) 33 (17.5%) 34 (26.6%)
Dead (n, %) 185 (23.2%) 51 (27.6%) 57 (19.3%) 41 (21.7%) 36 (28.1%)
Time to RRT (days) 2022 (752–3218) 2115 (1281–3386) 1863 (706–2976) 2395 (1332–3485) 1430 (213–2924)
Time to death (days) 2358 (1419–3535) 2299 (1495–3415) 2283 (1361–3304) 2680 (1853–3822) 1924 (701–3731)
Death or RRT (n, %) 296 (37.1%) 69 (37.3%) 113 (38.3%) 61 (32.3%) 53 (41.4%)
Time to death or RRT (days) 2027 (752–3230) 2145 (1281–3386) 1863 (706–3001) 2380 (1258–3420) 1430 (213–2924)
Mean (standard deviation) or median (interquartile range). uPCR, urinary protein to creatinine ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; follow-
up, mean or median during first 2 years of follow-up; T1–3, Tertiles 1–3.
Table 2. Baseline demographics and outcomes by deprivation tertile
All cases (n ¼ 797) T1 —most deprived (n ¼ 378) T2 (n ¼ 220) T3 — least deprived (n ¼ 199)
Male (n, %) 512 (64.2) 234 (61.9) 148 (67.3) 130 (65.3)
Age (years) 54.1 (17.0) 53.8 (16.4) 54.7 (16.8) 54.2 (18.2)
Baseline serum creat (lmol/L/1.73 m2) 128 (90–207) 130 (95–220) 128 (90–181) 120 (85–192)
Baseline uPCR (mg/mmol) 346 (154–702) 370 (143–689) 315 (148–714) 360 (179–736)
SBP baseline (mmHg) 144 (24) 146 (24) 142 (26) 141 (21)
DBP baseline (mmHg) 80 (13) 81 (13) 79 (12) 77 (11)
SBP follow-up (mmHg) 134 (31) 134 (30) 138 (26) 128 (36)
DBP follow-up (mmHg) 74 (17) 74 (17) 76 (15) 71 (20)
uPCR follow-up (mg/mmol) 122 (49–314) 125 (48–299) 111 (42–314) 124 (61–363)
RRT (n, %) 174 (21.8%) 90 (23.8%) 49 (22.3%) 35 (20.1%)
Dead (n, %) 185 (23.2%) 107 (28.3%) 51 (23.2%) 27 (13.6%)
Time to RRT (days) 2022 (752–3218) 1973 (634–3215) 2025 (771–3134) 2148 (1056–3403)
Time to death (days) 2358 (1419–3535) 2325 (1354–3436) 2326 (1493–3149) 2399 (1500–3684)
Follow-up (days) 2299 (1367–3446) 2308 (1334–3425) 2280 (1302–3264) 2372 (1438–3661)
Death or RRT (n, %) 296 (37.1%) 158 (41.8%) 82 (37.3%) 56 (28.1%)
Time to death or RRT (days) 2027 (752–3230) 1982 (635–3215) 2024 (771–3134) 2169 (1056–3403)
Mean (standard deviation) or median (interquartile range). uPCR, urinary protein to creatinine ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; follow-
up, mean or median during first 2 years of follow-up; T1–3, Tertiles 1–3.







(n ¼ 199) P
RRT (n ¼ 174) 90 (24%) 49 (22%) 35 (18%) 0.22
Death (n ¼ 185) 107 (28%) 51 (23%) 27 (14%) <0.001
Death or RRT (n ¼ 296) 158 (42%) 82 (37%) 56 (28%) 0.005
T1–3, Tertiles 1 (most deprived) to 3 (least deprived). Comparison bychi-square test.
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economic deprivation at the time of a diagnosis of IgAN is inde-
pendently associated with a 2.7-fold increased risk of death
(P¼ 0.03), independent of age, serum creatinine at diagnosis and
blood pressure. There was not an increased risk of requiring
RRT in these patients. The same pattern was seen in FSGS,
where deprivation Tertile 1 conferred a 7.4-fold increased risk
of death (P¼ 0.002), independent of age, serum creatinine at
baseline and blood pressure. However, living in a more deprived
area was not a significant predictor of risk of requiring RRT in
patients with FSGS.
Cause of death
The cause of death was not available for all patients but 14 pa-
tients died of ischaemic heart disease, 10 patients died of other
vascular disease, 19 died of sepsis, 10 deaths were due to malig-
nancy and 10 patients died of other causes.
Discussion
In this study, we have demonstrated a significant 2-fold
increased risk of death in patients with primary GN, who live in
an area of multiple socio-economic deprivation at the time of
diagnosis, compared with those living in relative affluence. This
association is independent of age, baseline renal function, blood
pressure control and proteinuria. Patients living in deprived
areas were not more likely to require RRT for ESRD.
This is the first study to look at the impact of deprivation on
patients with a diagnosis of primary GN and not simply CKD,
which encompasses a multitude of causes and associations [11].
The overall death rate of 23% in the study, during a median
follow-up of 6.3 years, is remarkable and highlights that a diag-
nosis of primary GN carries significant burden for patients,
strengthening the argument for aggressive risk factor modifica-
tion. Although the cause of death was only available for a mi-
nority of patients, the causes were diverse and not purely
cardiovascular or malignancy-related.
Living in an area of multiple socio-economic deprivation is
known to confer an increased mortality risk compared with liv-
ing in relative affluence. In Scotland, life expectancy is 13 years
shorter among males born in the most deprived decile com-
pared with the least deprived decile [1]. Scotland has the lowest
life expectancy in Western Europe and Glasgow has the lowest
life expectancy within Scotland, suggesting that the differences
seen here may be augmented compared with other geograph-
ical areas.
In the general population in Scotland, at the age of 55 years
(the average seen in this cohort), men can expect to live a fur-
ther 25 years and women a further 28 years [12]. However, this
does vary significantly by geography. Among the general
population in SIMD Tertile 1, men have an average life expect-
ancy of 23.0 years and women 26.2 years at the age of 55 years,
while in Tertile 3 this rises to 27.7 years for men and 29.9 years
for women. Therefore, it appears that the mortality risk seen
in patients in this study is above the national average and that
Table 4.Multivariate analysis of time to death
Univariate Multivariate
Factor HR CI HR P HR CI HR P
Age 1.073 1.061–1.085 <0.001 1.082 1.066–1.097 <0.001
Creatinine baseline 1.002 1.002–1.003 <0.001 1.003 1.002–1.004 <0.001
uPCR baseline 1.00 0.99–1.0 0.317
SIMD Tertile 1 2.17 1.42–3.31 <0.001 2.26 1.373–3.719 0.001
SBP baseline 1.01 1.003–1.018 0.007 1.001 0.994–1.008 0.761
uPCR median over 1st 2y 1.00 0.99–1.01 0.844
Time to death (185 deaths) by Cox proportional hazards model in the whole cohort. Non-significant univariate predictors: baseline diastolic blood pressure or follow-
up blood pressure, protein:creatinine ratio (uPCR). HR, hazard ratio; CI, confidence interval; SBP, systolic blood pressure.
Table 5.Multivariate analysis of time to RRT
Univariate Multivariate
Factor HR CI HR P HR CI HR P
Creatinine
baseline
1.006 1.005–1.007 <0.001 1.006 1.006–1.007 <0.001
SIMD Tertile 1 1.517 1.016–2.265 0.042
SBP baseline 1.014 1.007–1.022 <0.001 1.011 1.001–1.02 0.03
SBP follow-up 1.013 1.003–1.023 0.01
DBP baseline 1.022 1.008–1.036 0.002
Time to RRT (165 events—9 occurred prior to biopsy and were excluded) by Cox
proportional hazards model in the whole cohort. Non-significant univariate pre-
dictors were follow-up diastolic blood pressure, baseline or follow-up urinary
protein excretion and age. HR, hazard ratio; CI, confidence interval; SBP, systolic
blood pressure; DBP, diastolic blood pressure.



























Fig. 1. Cox regression survival curve of time to death (days)—all cases, separated
by tertile of deprivation. P ¼ 0.001. T1–3, Tertiles 1–3.
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the difference seen with deprivation (2- to 7-fold increase in
IgA and FSGS) is greater than would be expected. It also sug-
gests that the absence of such an association in MGN is
unusual.
The influence of multiple socio-economic deprivation on
health has been described as a reflection of inequality in the
distribution of power, money and resources in society.
Inequalities lead to differences in income, employment, educa-
tion and daily living conditions, and are linked to negative
health behaviours including smoking, poor diet, alcohol misuse
and other factors, all of which impact upon an individuals’ risk
of morbidity and mortality [13]. Influencing these complex and
long-term inequalities requires a population level social and
economic intervention and is the focus of much research in
Scotland. When reviewing patients in the clinic, it is important
to bear in mind the environmental and contextual factors for
each patient and to target interventions appropriately.
Whether the increased risk of death seen in this study
among patients from deprived areas is an effect of health be-
haviours such as diet, smoking and alcohol, and independent of
renal specific factors, was beyond the scope of this study. It
would be impossible to separate out the influence of structural
and environmental factors and of health behaviour with any de-
gree of certainty. Perhaps renal disease and the impact upon
cardiovascular risk [14] has a synergistic effect with these life-
style choices. Scotland was one of the first country to ban smok-
ing in public places and is attempting to introduce a minimum
pricing strategy for alcohol; however, any impact of these meas-
ures on outcomes for patients with GN and other conditions
will not be seen for many years.
The fact that the effect differs by primary renal disease,
however, counts against a generic effect of CKD and reduced
estimated glomerular filtration rate. The effect was most
marked in patients with FSGS but was completely absent in pa-
tients with membranous nephropathy. Whether this is because
patients with MGN are older at diagnosis and their burden of
risk is already established or whether IgAN and FSGS have en-
vironmental associations is not clear. Also, the recent discovery
of the anti-PLA2 receptor antibody [15] suggests that idiopathic
MGN is a primary autoimmune condition and the natural
history and systemic effects may differ from those of IgAN and
FSGS, which have more systemic associations.
A previously reported correlation between low birth weight
and renal disease is interesting [16], with lower nephron num-
ber resulting in nephromegaly and perhaps an increased sus-
ceptibility to glomerular disease. Low birth weight is more
common in areas of socio-economic deprivation and might ex-
plain some of the increased risk seen.
The lack of association between deprivation status and risk
of requiring RRT is curious in light of the strong association
with mortality. The reported association between incidence of
ESRD and requirement for RRT in patients from areas of mul-
tiple deprivation may have more to do with prevalence of dis-
ease than greater rates of progression. Predictors of requiring
RRT in this study were renal function at baseline and blood
pressure, both of which were associated with the risk of death.
It is perhaps reassuring that in a health service free at the point
of access, deprivation appears to have no impact upon renal
outcomes, although access to healthcare is affected by more
than cost. There may also be an issue of competing risk, with
patients from more deprived areas dying before reaching ESRD
and therefore any excess risk is lost.
Scotland, as a whole, is not racially diverse and over 90% of
patients included in this study are White British, suggesting
that differences in outcome are not related to race. Also, al-
though there are wide differences in relative affluence in
Scotland, it is a first world country where there is universal ac-
cess to clean water, sanitation and health care. Communicable
diseases are infrequent.
Further study is required to establish whether aggressive car-
diovascular risk modification improves mortality rate in primary
GN, where research tends to focus on the progression of disease
to end-stage renal failure. It would also be valuable to investigate
whether certain patient groups, such as those living in relative
deprivation, benefit more than others from these interventions.
Also, many primary renal diagnoses represent a spectrum of dis-
ease, collected together by histological appearance, which may
reflect differing pathogenesis, and further study of environmen-
tal effects on renal disease is merited.
Our data relating to patients with primary renal disease are
complete and no patients were lost to follow-up.
Limitations
This study is an observational study. Therefore, we only report
associations and cannot determine causality. SIMD is a popula-
tion measure of multiple deprivation, rather than an individual
level measure, meaning that patients can live in a deprived area
but may not in fact be deprived. More complete data on cause of
death may have shed more light on the mechanism underlying
the observed increased risk of death. A measure of comorbidity
including diabetes would have been valuable. Information
about medications taken during follow-up, such as anti-
platelets, inhibitors of the renin angiotensin system and statin
therapy might have been revealing. We were unable to deter-
mine whether the diagnosis of FSGS was primary or secondary,
which would have been useful to ascertain.
Conclusions
In this novel study looking at the association between living in
an area of multiple deprivation and being diagnosed with a pri-
mary glomerular disease, we have shown that patients who live
in a deprived area have at least a 2-fold increased risk of death
Table 6. Primary endpoints by primary renal disease
Membranous nephropathy
Category T1 (n ¼ 93) T2 (n ¼ 47) T3 (n ¼ 45) P
RRT (n ¼ 27) 13 (14%) 10 (21%) 4 (9%) 0.236
Death (n ¼ 51) 25 (27%) 14 (30%) 12 (27%) 0.925
Death or RRT (n ¼ 69) 32 (34%) 21 (45%) 16 (36%) 0.476
IgAN
Category T1 (n ¼ 143) T2 (n ¼ 85) T3 (n ¼ 67) P
RRT 44 (31%) 19 (22%) 17 (25%) 0.36
Death 37 (26%) 14 (17%) 6 (9%) 0.011
Death or RRT 66 (46%) 27 (32%) 20 (30%) 0.026
FSGS
Category T1 (n ¼ 78) T2 (n ¼ 57) T3 (n ¼ 57) P
RRT 16 (20.5%) 10 (18.5%) 7 (12.3%) 0.448
Death 25 (32.1%) 12 (22.2%) 4 (7.0%) 0.002
Death or RRT 31 (39.7%) 19 (35.2%) 11 (19.3%) 0.037
T1–3, Tertiles 1–3; T1, most socio-economically deprived area. Estimate of sig-
nificance using chi-square test. P < 0.05 ¼ significant.
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compared with those who live in relative affluence. This
increased risk is greater than would be expected from the back-
ground population, suggesting an interplay between renal dis-
ease and the environment. Interestingly, no association with
the risk of requiring RRT was seen, which may reflect the com-
peting risk of death. The effect on mortality is not equal across
all primary renal diseases and is absent in MGN but significantly
increased in IgAN and FSGS, suggesting that further study
should be directed towards the mechanisms of disease in these
conditions.
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